{
  "docId": "019de076-3901-734c-833f-b5b0e2d3aa41",
  "docSlug": "e86c5f257c7f518e1f9c16c922f96c7d",
  "documentTitle": "Exscientia | Investor Presentation Deck | 76 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 72,
  "pageCount": 76,
  "prevPage": 71,
  "nextPage": 73,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses two dose-response curves to demonstrate selectivity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-3901-734c-833f-b5b0e2d3aa41/72",
  "deckHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41",
  "deckJsonHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41.json",
  "deckAnchorHref": "/decks/019de076-3901-734c-833f-b5b0e2d3aa41#slide-72",
  "components": [
    {
      "bbox": {
        "h": 0.48,
        "w": 0.42,
        "x": 0.51,
        "y": 0.215
      },
      "kind": "chart",
      "text": "Dose-response curve for T-cell viability",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e00e338-94ce-446a-afd5-58e64a77a29e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.48,
        "w": 0.42,
        "x": 0.07,
        "y": 0.215
      },
      "kind": "chart",
      "text": "Dose-response curve for CLL cell inhibition",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d7932e9-fffc-4ea1-896e-ec7a6e427096",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.11,
        "y": 0.725
      },
      "kind": "list",
      "text": "CLL samples from both treatment naïve patients and patients exposed to previous lines of therapy\n‘565 selectively inhibited the proliferation of primary human CLL cells\nLimited impact of ‘565 observed on T-cell viability",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9190d2b-736c-49dc-a063-3db79b48ad50",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Payne et al. ESMO, 2023",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f39d3567-532e-4828-9dd6-309500887037",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.78,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Efficacy in primary human tissues without impacting T-cell viability",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25334eb0-5d5e-4586-9185-57eec6705ac9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "‘565 inhibits primary human CLL cell proliferation",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4d99df9-08f8-4b86-8076-89a0f82563ad",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "7d5dd793-635f-4e31-b91d-7ddaae36f23e",
      "evidence": "chart/line: Dose-response curve for CLL cell inhibition and chart/line: Dose-response curve for T-cell viability",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}